DocWire News Editors

DocwireNews

A study recently conducted at the University of Helsinki indicates that two episodic memory tests can help in predicting <a href="https://proddocwire.wpengine.com/docwire-pick/future-of-medicine-picks/the-wayback-project-vr-helping-people-with-alzheimers/">Alzheimer&rsquo;s disease</a> and brain degeneration. &nbsp;These memory tests helped to identify individuals with increased risk of receiving Alzheimer&rsquo;s diagnosis within the next coming three years. The research team believes that use of these memory tests could greatly improve the diagnosis of mild cognitive impairment caused by Alzheimer&rsquo;s.In the study, researchers assessed data from 230 cognitively normal patients and 394 with mild cognitive impairment from the Alzheimer&rsquo;s Disease Neuroimaging Initiative (ADNI). Mild cognitive impairment was deemed in those with poor memory performance in one measure of episodic memory, particularly in story recall. Grade of cognitive impairment was further differentiated by whether the individual showed impaired memory in only story recall, or for story and word list recalls.The scientists evaluated the baseline differences between the groups via cerebrospinal fluid indicators of Alzheimer&rsquo;s disease, finding that those who expressed poor performance on both memory tests were more related to Alzheimer&rsquo;s patients than those who only showed poor performance on one.&ldquo;During the follow-up stage, brain atrophy in the medial temporal lobes of those who only performed poorly in the story recall test did not differ from the cognitively healthy participants, whereas in those who had poor performance in both the story and word list recall tests, brain atrophy was faster,&rdquo; said Eero Vuoksimaa, an Academy of Finland research fellow at the University of Helsinki.<a href="https://proddocwire.wpengine.com/docwire-pick/future-of-medicine-picks/bill-gates-new-investment-seeks-to-revolutionize-alzheimers-testing/">READ MORE:&nbsp;Bill Gates&rsquo; New Investment Seeks to Revolutionize Alzheimer&rsquo;s Testing</a>Alzheimer&rsquo;s disease was identified in roughly half of the participants who did poorly on both episodic memory tests in the three-year study. Compared to only 16% of those being diagnosed with Alzheimer&rsquo;s who did poorly on only one test, these results argue that these tests can be very efficient in predicting Alzheimer&rsquo;s in patients.&ldquo;The use of two memory tests markedly improved the accuracy of the prognosis for an Alzheimer&rsquo;s disease diagnosis and brain atrophy in the medial temporal lobes during a three-year follow-up period,&rdquo; said Vuoksimaa. &ldquo;The results highlight the importance of neuropsychological assessment as a cost-effective method of diagnosing mild cognitive impairment due to Alzheimer&rsquo;s disease.&rdquo;<a href="https://proddocwire.wpengine.com/docwire-pick/future-of-medicine-picks/researchers-use-artificial-intelligence-ai-to-predict-alzheimers-years-before-diagnosis/">READ MORE:</a> Researchers Use Artificial Intelligence (AI) to Predict Alzheimer&rsquo;s Years Before DiagnosisMild cognitive impairment is a heterogenous condition that can be either reversible or permanent. The condition is constituted by impairment of memory and or other cognitive domains in scenarios where an individual can still independently conduct daily activities. It is important that mild cognitive impairment is not criteria for Alzheimer&rsquo;s or related dementia diseases, but it is associated with elevated risks of later developing dementia.Vuoksimaa elaborates on the team&rsquo;s research, stating: &ldquo;Indeed, more comprehensive neuropsychological assessment including at least two episodic memory tests could be introduced as part of the health evaluation of the aging population, particularly in cases where memory impairment is suspected. Our method could also be used when selecting participants for clinical drug trials. When looking for preventive drug therapy for Alzheimer&rsquo;s disease, it would be important to be able to identify those individuals whose early cognitive impairment is due to Alzheimer&rsquo;s disease.&rdquo;<blockquote class="twitter-tweet" data-lang="en">
Memory tests predict brain atrophy and Alzheimer&rsquo;s disease | University of Helsinki <a href="https://t.co/oFTZxR0Jzf">https://t.co/oFTZxR0Jzf</a> <a href="https://twitter.com/amchelsinki?ref_src=twsrc%5Etfw">@amchelsinki</a>
&mdash; P&auml;ivi M. Lehtinen (@PviLe) <a href="https://twitter.com/PviLe/status/1072072499544907776?ref_src=twsrc%5Etfw">December 10, 2018</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>Source: <a href="https://www.sciencedaily.com/releases/2018/12/181210101942.htm">ScienceDaily</a>

Jayme Locke, MD, MPH

Joel M. Topf, MD, FACP

The Promise of Xenotransplantation

NKF Spring Clinical Meetings 2025

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Sacituzimab Govitecan Showed Modest Activity for CNS Metastases

Triple-Negative Breast Cancer

Latest News

Memory Tests Found to Be Strong Predictors of Alzheimer's Disease

Dementia

A study recently conducted at the University of Helsinki indicates that two episodic memory tests can help in predicting Alzheimer’s disease and brain degeneration.  These ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe